NOS3 and breast cancer: As E298D and −786T>C polymorphisms in NOS3 result with lower eNOS expression and nitric oxide synthesis and reduced risk for breast cancer 66, eNOS, as well as iNOS, may play roles in the aetiology of gynaecological cancers.